drugset / Trial / NCT00450073

Improving Vitamin D Status In Cystic Fibrosis

NCT00450073

RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to establish an effective method to correct vitamin D deficiency in subjects with cystic fibrosis. The investigators will examine cholecalciferol, ergocalciferol and UV light.

Timeline

Start
2006-11
Primary completion
2011-05
Completion
2011-05

Drugs

EvaluationDrugModalityDoseRoute
Comparator Cholecalciferol Other / unclassified 50000 iu Oral
Comparator Ergocalciferol Small molecule 50000 iu

Indications